相关实验视频

Updated: May 22, 2025

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments

Published on: November 9, 2017

实验性自身免疫性神经炎神经脱线被通过阻断JAK2/STAT3信号通路减弱在老鼠中

Rumeng Zhou¹, Shuping Liu¹, Yue Liu¹

¹Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.

Brain and behavior

|May 19, 2025

概括

抑制JAK2/STAT3通路减少了Guillain-Barré综合征 (GBS) 的大鼠模型中的炎症和改善了临床评分. 这表明JAK2/STAT3是GBS的潜在治疗点.

科学领域:

神经科学是一个神经科学.
免疫学免疫学免疫学
药理学药理学是指药理学的学科.

背景情况:

吉兰-巴雷综合征 (GBS) 是一种免疫媒介的外围神经病变.
JAK-STAT信号通路参与细胞因子信号传递,但其在GBS中的作用尚不清楚.
AG490是一种JAK2抑制剂,可以降低STAT3酸化的调节.

研究的目的:

为了研究JAK2/STAT3信号通路在实验性自身免疫神经炎 (EAN) 中的作用,GBS的老鼠模型.
在 EAN 中使用 AG490 评估抑制 JAK2/STAT3 的治疗潜力.

主要方法:

路易斯大鼠使用P2来诱导使用EAN.
AG490 (10毫克/公斤) 每隔一天服用,从免疫接种后的第五天开始.
评估了临床分数,坐骨神经组织学 (H&E,CD45,LFB),细胞因子水平 (TGF-β1,IFN-γ,IL-6),以及JAK2/STAT3通路激活 (西斑,免疫光).

主要成果:

AG490治疗改善了临床评分,并减少了EAN大鼠的坐骨神经中的炎症透和髓损失.
AG490显著降低了TGF-β1,IFN-γ和IL-6的高水平.
在EAN中观察到JAK2/STAT3通路的激活,AG490治疗减少了p-JAK2和p-STAT3的表达.

结论:

JAK2/STAT3信号通路在EAN的发病过程中发挥着重要作用.
用AG490抑制JAK2/STAT3有效降低了炎症,并在EAN大鼠模型中改善了结果.
这项研究提供了对人类GBS潜在治疗点的见解.

关键词:

AG49090 AG49090 AG49090 AG490 AG490 AG490 AG490 AG490 AG490 AG490 AG490 AG490 这是JAK-STAT信号通道.实验性的自身免疫性神经炎治疗治疗治疗治疗治疗治疗

更多相关视频

Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo

Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo

Published on: March 26, 2019

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

相关概念视频

The JAK-STAT Signaling Pathway

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...